Mr. Chair, I think the record shows that Canada is an attractive country for clinical trials. As I indicated, we have a very competitive regime. Special measures were put in place for COVID-related clinical trials, but otherwise, we have a competitive regime, which we are setting out to modernize. The government has invested through the budget $250 million to strengthen the clinical trials research. National networks have been established. These factors have led to the continued submission of clinical trials in Canada.
